JP2024532249A5 - - Google Patents

Info

Publication number
JP2024532249A5
JP2024532249A5 JP2024511970A JP2024511970A JP2024532249A5 JP 2024532249 A5 JP2024532249 A5 JP 2024532249A5 JP 2024511970 A JP2024511970 A JP 2024511970A JP 2024511970 A JP2024511970 A JP 2024511970A JP 2024532249 A5 JP2024532249 A5 JP 2024532249A5
Authority
JP
Japan
Prior art keywords
oxy
cyclobutyl
amino
acrylamide
methoxyquinazoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024511970A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024532249A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/041218 external-priority patent/WO2023028054A1/en
Publication of JP2024532249A publication Critical patent/JP2024532249A/ja
Publication of JP2024532249A5 publication Critical patent/JP2024532249A5/ja
Pending legal-status Critical Current

Links

JP2024511970A 2021-08-24 2022-08-23 疾患の処置のためのキナゾリン化合物 Pending JP2024532249A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163236581P 2021-08-24 2021-08-24
US63/236,581 2021-08-24
PCT/US2022/041218 WO2023028054A1 (en) 2021-08-24 2022-08-23 Quinazoline compounds for treatment of disease

Publications (2)

Publication Number Publication Date
JP2024532249A JP2024532249A (ja) 2024-09-05
JP2024532249A5 true JP2024532249A5 (https=) 2025-08-25

Family

ID=85323427

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024511970A Pending JP2024532249A (ja) 2021-08-24 2022-08-23 疾患の処置のためのキナゾリン化合物

Country Status (10)

Country Link
US (1) US20250243171A1 (https=)
EP (1) EP4392423A4 (https=)
JP (1) JP2024532249A (https=)
KR (1) KR20240069728A (https=)
AR (1) AR126849A1 (https=)
AU (1) AU2022332906A1 (https=)
CA (1) CA3229692A1 (https=)
IL (1) IL310870A (https=)
TW (1) TW202328105A (https=)
WO (1) WO2023028054A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12145917B2 (en) 2018-12-06 2024-11-19 Arthrosi Therapeutics, Inc. Crystalline forms of a compound for treating or preventing gout or hyperuricemia
TW202309022A (zh) 2021-04-13 2023-03-01 美商努法倫特公司 用於治療具egfr突變之癌症之胺基取代雜環
CN115894486B (zh) * 2021-09-30 2024-02-09 北京赛特明强医药科技有限公司 一种氢化吡啶并喹唑啉类化合物、组合物及其应用
WO2024059169A1 (en) * 2022-09-14 2024-03-21 Blueprint Medicines Corporation Egfr inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5323907A (en) 1992-06-23 1994-06-28 Multi-Comp, Inc. Child resistant package assembly for dispensing pharmaceutical medications
JP4776882B2 (ja) * 2002-03-30 2011-09-21 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 二環式複素環化合物、これらの化合物を含む医薬組成物、それらの使用及びそれらの調製方法
TWI377944B (en) * 2007-06-05 2012-12-01 Hanmi Holdings Co Ltd Novel amide derivative for inhibiting the growth of cancer cells
CN104513229A (zh) * 2013-09-28 2015-04-15 正大天晴药业集团股份有限公司 喹唑啉衍生物及其制备方法
WO2019120213A1 (zh) * 2017-12-19 2019-06-27 南京明德新药研发股份有限公司 喹唑啉衍生物及其应用
WO2019233459A1 (zh) * 2018-06-08 2019-12-12 江苏威凯尔医药科技有限公司 人表皮生长因子受体抑制剂及其制备方法和应用
EP3962908A4 (en) * 2019-04-25 2022-10-26 Board of Regents, The University of Texas System HETEROCYCLIC INHIBITORS OF TYROSINE KINASE
CN112079830B (zh) * 2019-06-14 2023-12-22 上海翰森生物医药科技有限公司 含并环类衍生物抑制剂、其制备方法和应用
CN111763215B (zh) * 2020-07-21 2021-05-18 成都海博为药业有限公司 一种具有含氮杂环结构的化合物及其制备方法和用途

Similar Documents

Publication Publication Date Title
JP2024532249A5 (https=)
JP2021523200A5 (https=)
JP2021514001A5 (https=)
RU2494095C2 (ru) Модифицированные миметики лизина
JP2020529994A5 (https=)
JP2024514837A5 (https=)
JP2024520481A5 (https=)
ES2670571T3 (es) Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis B
JP2005508349A5 (https=)
JP2024516033A5 (https=)
JP2021513534A5 (https=)
RU2011103234A (ru) Новые фенилпиразиноны в качестве ингибиторов киназы
RU2009103899A (ru) Циклопента(d)пиримидины в качестве ингибиторов протеинкиназ
JP2020511536A5 (https=)
JP2022510925A5 (https=)
JP2022525069A5 (https=)
JP2021512109A5 (https=)
JP2017525737A5 (https=)
RU2011124150A (ru) Нафтилуксусные кислоты
JP2023518044A5 (https=)
RU2008107733A (ru) Ингибиторы gsk-3
JP2023504542A5 (https=)
JP2022509206A5 (https=)
JP2021536505A5 (https=)
JP2025527291A5 (https=)